Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Health effects research in oil shale development

Technical Report ·
DOI:https://doi.org/10.2172/5993819· OSTI ID:5993819
This task includes the testing of primary effluents and products of oil shales to determine the risk posed to the shale oil industrial worker as well as consumer. Paraho/Sohio Shale Oil was found to be mutagenic in the Ames assay and confirmed in the yeast system. After chemical fractionation of the crude shale oil, it was found that the mutagenic activity was contributed by the organic constituents of the basic and neutral fractions. Hydrotreatment of the shale oil abolished the detectable mutagenic activity and also reduced the cytotoxicity as measured in cellular systems. Refined shale oil, jet fuel, and diesel fuel marine samples were not mutagenic. The samples rank for their mutagenic activity as coal oils > shale oil > natural petroleum crudes and only qualitatively agree with carcinogenic activity. Acute toxicity of Paraho Crude Shale Oil and its upgraded derivatives does not appear to be a problem of immediate concern. The data obtained in the lung adenoma bioassay suggest that Crude Shale Oil has tumorigenic potential. Paraho shale oil is carcinogenic in mouse skin. Hydrotreatment reduces but does not eliminate skin carcinogenicity and appreciable carcinogenic activity remains in the residue material. Kidney injury was noted following chronic dermal exposure to shale and petroleum derived middle distillates.
Research Organization:
Oak Ridge National Lab., TN (USA)
DOE Contract Number:
W-7405-ENG-26
OSTI ID:
5993819
Report Number(s):
ORNL/TM-8034; ON: DE82002911
Country of Publication:
United States
Language:
English